RPRX vs ALNY: Fair Value Comparison

Royalty Pharma Plc vs. Alnylam Pharmaceuticals Inc · Biotechnology

RPRX's model fair value sits 32.1% below its current price; ALNY's model fair value sits 3.0% below its current price. Of the two, ALNY trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.

RPRXALNY
Price$63.96$227.47
Model fair value (multi-method blend)$43.42$220.56
Model fair value differential-32.1%-3.0%
Methods with a model value above price6 of 86 of 8
Fundamental strengthBA-
Next earnings report2026-11-042026-10-29

Differential = model fair value versus the current price; positive means the price sits below the model estimate.

More comparisons

VRTX vs RPRX · REGN vs RPRX · ARGX vs RPRX · ONC vs RPRX · VRTX vs ALNY · REGN vs ALNY · ARGX vs ALNY · ONC vs ALNY · All Biotechnology stocks · Compare any two stocks